GHAPPcast

Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)
  • 0,0 (0)
  • MEDICINA
GHAPPcast

This is the official podcast of The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP), an association is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs). Through our peer-to-peer network, we seek to support their integral role in the specialty healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).

  1. GHAPPcast: CD64+ Binding: Description, Relevance, and Potential Clinical Implications

    HÁ 2 DIAS

    GHAPPcast: CD64+ Binding: Description, Relevance, and Potential Clinical Implications

    Join Gabriella McCarty, NP-C and Andrea Banty, NP, as they explore the role of CD64-positive binding and IL-23 inhibition in IBD treatment. Discover how these mechanisms impact Crohn’s disease and ulcerative colitis management, offering insights into emerging therapies and clinical applications. Subscribe for more GI and hepatology updates!

    12min
  2. FAQ: Provide immunologic rationale for IL23 directed therapy in IBD(+ general overview of Guselkumab MOA)

    HÁ 4 DIAS

    FAQ: Provide immunologic rationale for IL23 directed therapy in IBD(+ general overview of Guselkumab MOA)

    Sarah Enslin, PA-C, from the University of Rochester Medical Center, explains the role of IL-23 in driving inflammation in IBD and how IL-23-directed therapies like Guselkumab target this pathway. Learn how this selective inhibition reduces inflammation while preserving essential immune functions, improving patient outcomes in Crohn's disease and ulcerative colitis.

    2min

  3. 9 DE JAN.

    Journal Club: Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis

    Shaya Schoenoff, PA-C, reviews the efficacy and safety of Guselkumab induction therapy for moderately to severely active ulcerative colitis. Explore key findings from the Phase 2B and Phase 3 QUASAR induction studies, highlighting clinical response, endoscopic improvement, and safety outcomes compared to placebo. Learn how Guselkumab offers promising results for patients with inadequate response to conventional or advanced therapies.

    5min
  4. Medication Review: What is non-responder imputation and how is it utilized in clinical trials?

    7 DE JAN.

    Medication Review: What is non-responder imputation and how is it utilized in clinical trials?

    Whitney Steinmetz, NP, explains non-responder imputation, a common statistical method used in clinical trials to handle missing data. Learn how this approach impacts trial results, its advantages in reducing bias, and its limitations in estimating treatment effectiveness. Gain insights into interpreting clinical trial data to make informed patient care decisions.

    2min
  5. FAQ: What is the role of IL23/IL17 axis in IBD

    17/12/2024

    FAQ: What is the role of IL23/IL17 axis in IBD

    Amy Stewart, ARNP, from Capital Digestive Care, explains the role of the IL-23/IL-17 axis in inflammatory bowel disease (IBD). Learn how these cytokines drive chronic inflammation and their significance in IBD pathogenesis, as well as how targeted therapies address these pathways.

    2min
  6. Describe the IL23/IL17 axis

    12/12/2024

    Describe the IL23/IL17 axis

    In this video, Erica Heagy, NP, from Alaska Digestive and Liver Disease, discusses the IL-23/IL-17 axis and its role in inflammatory bowel disease (IBD) and other immune-mediated conditions. Learn how the IL-23 cytokine promotes differentiation of CD4+ T cells into Th17 cells, stimulating the production of IL-17A, IL-17F, TNF, and IL-6. This pathway is critical in diseases like psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, and axial spondyloarthritis. Targeting IL-23 or...

    2min
  7. GHAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of IBD

    12/12/2024

    GHAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of IBD

    Join Gabriella McCardy, NP, and guest Ali Crentes, NP, as they dive into the IL-23/IL-17 axis and its critical role in inflammatory bowel disease (IBD). This episode explores the pathogenesis of IBD, targeted therapies, and practical approaches to patient care. Gain insights into how understanding these pathways can improve outcomes and inform shared decision-making.

    12min

  8. 05/12/2024

    Medication Review: Describe the mechanism of action of guselkumab

    Discover the science behind Guselkumab and its role in treating inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease. Whitney Steinmetz, NP, from Presbyterian Medical Group in Albuquerque, NM, explains the mechanism of action of Guselkumab.

    2min
Ver tudo (45)

Sobre

This is the official podcast of The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP), an association is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs). Through our peer-to-peer network, we seek to support their integral role in the specialty healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).

Informações

  • Criado por
    Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)
  • Anos de atividade
    2023 - 2025
  • Episódios
    45
  • Classificação
    Livre
  • Copyright
    © 2025 GHAPPcast
  • Site do podcast
    GHAPPcast

Você também pode gostar de

Para ouvir episódios explícitos, inicie sessão.

Fique por dentro deste podcast

Inicie sessão ou crie uma conta para seguir podcasts, salvar episódios e receber as atualizações mais recentes.
Selecionar um país ou região

África, Oriente Médio e Índia

Ásia‑Pacífico

Europa

América Latina e Caribe

Estados Unidos e Canadá